Evoke Pharma, Inc. (EVOK)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Matthew J. D'Onofrio MBA | Co-Founder, CEO & Director | 779.37k | -- | 1970 |
| Dr. Marilyn R. Carlson D.M.D., M.D., RAC. | Chief Medical Officer | 681.24k | -- | 1948 |
| Mr. Mark A. Kowieski CPA | Chief Financial Officer | -- | -- | 1977 |
| Mr. Christopher Quesenberry | Chief Commercial Officer - Gimoti (TM) | -- | -- | -- |
Evoke Pharma, Inc.
- Sector:?
- Healthcare
- Industry:? Drug Manufacturers - Specialty & Generic
- Full Time Employees:?
- 4
Description
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Corporate Governance
Upcoming Events
November 7, 2024 at 1:30 PM UTC - November 11, 2024 at 1:30 PM UTC
Evoke Pharma, Inc. Earnings Date
Recent Events
September 4, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
August 19, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission